| |
Back to Infections Drug Index
Name: Vidarabine
Pregnancy Category C
Drug classes
Therapeutic actions
Antiviral activity against herpes simplex types 1 and 2; mechanism of
action has not been established; probably interferes with DNA synthesis.
Indications
Herpes simplex virus encephalitis (parenteral administration)
Neonatal herpes simplex virus infections (parenteral administration)
Herpes simplex virus keratitis (ophthalmic administration)
Reduction of complications of herpes zoster in immunocompromised patients
(parenteral product)
Contraindications/cautions
Contraindicated in the presence of allergy to vidarabine, pregnancy,
lactation.
Use caution in the presence of liver disease, psychoses, CHF, renal disease,
CNS infections.

|
|
|
|
Are you a doctor or a nurse?
Do you want to join the Doctors Lounge online medical community?
Participate in editorial activities (publish, peer review, edit) and
give a helping hand to the largest online community of patients.
Click on the link below to see the requirements:
Doctors Lounge Membership
Application |
|
Adverse effects Parenteral Administration
- CNS: Tremor, headache, psychoses, malaise, dizziness, confusion, irritability,
ataxia
- GI: Nausea, vomiting, anorexia, diarrhea
- Hematologic: Decreased reticulocyte count, hemoglobin, hematocrit,
WBC, platelet count, increased SGOT, total bilirubin
- Dermatologic: Pruritus, rash
- Local: Pain at injection site
- Other: Weight loss
Ophthalmic Administration
- Local: Blurring of vision, burning or stinging on administration,
photophobia
|
|